ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Add and Read Reviews
Other Men's Health Product or Company Reviews
Cost Plus Drug Company
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 249524" data-attributes="member: 13851"><p>[MEDIA=youtube]AHHiWfQTk5w[/MEDIA]</p><p></p><p>[ATTACH=full]30231[/ATTACH]</p><p></p><p><strong><em>A recording of the live stream from Vanderbilt University Medical Center on March 23, 2023. </em></strong></p><p><strong><em></em></strong></p><p><strong><em>Mark Cuban discusses how his Cost Plus Drug Company is innovating to lower prescription drug prices in America. The discussion explores the implications of the Journal of Urology paper that shows Cuban’s new drug company could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on the nine most popular urological drugs. </em></strong></p><p><strong><em></em></strong></p><p><strong><em>The study was authored by Talwar and Sam S. Chang, MD, MBA, Patricia and Rodes Hart Endowed Professor of Urologic Surgery and VUMC Chief Surgical Officer, Vanderbilt Ingram Cancer Center. </em></strong></p><p></p><p><em><strong>Stacie Dusetzina, Ph.D., Professor of Health Policy at Vanderbilt University Medical Center is also featured.</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 249524, member: 13851"] [MEDIA=youtube]AHHiWfQTk5w[/MEDIA] [ATTACH type="full"]30231[/ATTACH] [B][I]A recording of the live stream from Vanderbilt University Medical Center on March 23, 2023. Mark Cuban discusses how his Cost Plus Drug Company is innovating to lower prescription drug prices in America. The discussion explores the implications of the Journal of Urology paper that shows Cuban’s new drug company could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on the nine most popular urological drugs. The study was authored by Talwar and Sam S. Chang, MD, MBA, Patricia and Rodes Hart Endowed Professor of Urologic Surgery and VUMC Chief Surgical Officer, Vanderbilt Ingram Cancer Center. [/I][/B] [I][B]Stacie Dusetzina, Ph.D., Professor of Health Policy at Vanderbilt University Medical Center is also featured.[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Add and Read Reviews
Other Men's Health Product or Company Reviews
Cost Plus Drug Company
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top